UofL expands oncology research with addition of 33,000 human tissue samples

The University of Louisville has expanded its oncology research strength through the addition of approximately 33,000 human tissue samples and specimens. The samples were transferred by Catholic Health Initiatives (CHI) to further the shared commitment and collaboration in advancing research and action in the fight against cancer.

Researchers from the University of Louisville and James Graham Brown Cancer Center are partners with CHI through national oncological research between the two organizations, as well as locally as part of KentuckyOne Health. This close collaboration has delivered significant impact in the understanding of a variety of cancers and is supporting physicians and patients in Kentucky and across the country.

"These specimens provide our researchers with opportunities to build on existing research initiatives and open the door for new areas of study in fighting cancer," said Dr. James Ramsey, president of the University of Louisville. "We now will be able to extend our efforts to build upon our advances and we continue to work to reduce the human costs of cancer."

Research teams in Louisville now have access to triple the number of medical specimens to guide cancer research. The more than 47,000 samples in the University of Louisville biorepository cover 111 unique primary tumor sites and include cancer types that are particularly prevalent in Kentucky, including breast, lung, colon and kidney cancers.

"Cancer is one of the most prevalent health issues facing the people of the Commonwealth," said Ruth Brinkley, CEO of KentuckyOne Health. "The gifting of these specimens reinforces our shared commitment to bring wellness, health and hope to patients in Kentucky and across the country. The innovative treatments, diagnostic tests and other insights our local researchers are developing are critical to helping us reduce the rate and impact of cancer."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neoantigen vaccine sparks powerful immune defense against kidney cancer